QUINAPRIL HYDROCHLORIDE

QUINAPRIL HYDROCHLORIDE was reported 7855 times

QUINAPRIL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 60 0.6250
1 BLOOD MERCURY ABNORMAL 41 0.4184
2 5-HYDROXYINDOLACETIC ACID IN URINE INCREASED 21 0.3818
3 5-HYDROXYINDOLACETIC ACID INCREASED 20 0.3077
4 PROLONGED EXPIRATION 61 0.2328
5 SEDATION COMPLICATION 538 0.2106
6 CREATININE RENAL CLEARANCE DECREASED 518 0.1293
7 BRONCHOMALACIA 16 0.1212
8 MULTIPLE DRUG THERAPY 75 0.0995
9 CREATININE RENAL CLEARANCE INCREASED 58 0.0775
10 FIBROUS HISTIOCYTOMA 24 0.0684
11 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 24 0.0614
12 RENAL PHOSPHOLIPIDOSIS 7 0.0515
13 BLOOD CALCIUM DECREASED 526 0.0467
14 EPIDURAL HAEMORRHAGE 5 0.0385
15 PSEUDOHYPONATRAEMIA 5 0.0365
16 ORTHOSTATIC HYPOTENSION 623 0.0357
17 LOW DENSITY LIPOPROTEIN DECREASED 41 0.0289
18 MALIGNANT POLYP 5 0.0263
19 ALLERGY TO ARTHROPOD BITE 8 0.0250
20 SEDATION 579 0.0221
21 RECALLED PRODUCT ADMINISTERED 205 0.0215
22 MERYCISM 6 0.0210
23 DEPRESSIVE SYMPTOM 61 0.0173
24 COGWHEEL RIGIDITY 16 0.0152
25 RENAL FUNCTION TEST ABNORMAL 70 0.0151
26 DEPRESSED LEVEL OF CONSCIOUSNESS 538 0.0136
27 COGNITIVE DISORDER 635 0.0136
28 HEPATIC NEOPLASM 44 0.0135
29 HEAD TITUBATION 16 0.0116
30 RALES 67 0.0115
31 SPINAL CORD INFARCTION 5 0.0113
32 APPETITE DISORDER 63 0.0095
33 RESPIRATION ABNORMAL 65 0.0094
34 GINGIVAL DISCOMFORT 6 0.0091
35 INTENTION TREMOR 5 0.0088
36 UPPER AIRWAY OBSTRUCTION 7 0.0079
37 ARTERIOSCLEROSIS CORONARY ARTERY 51 0.0077
38 MOBILITY DECREASED 546 0.0076
39 HYPERPARATHYROIDISM SECONDARY 19 0.0076
40 NEPHROGENIC ANAEMIA 35 0.0075
41 ANTICHOLINERGIC SYNDROME 12 0.0075
42 BALANCE DISORDER 645 0.0075
43 FLANK PAIN 66 0.0070
44 CALCULUS URETERIC 5 0.0069
45 AORTIC VALVE SCLEROSIS 5 0.0068
46 INTERMITTENT CLAUDICATION 10 0.0063
47 REBOUND ACID HYPERSECRETION 19 0.0063
48 CARDIOPULMONARY FAILURE 23 0.0059
49 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
50 PRODUCT COATING ISSUE 5 0.0049
51 METABOLIC SYNDROME 8 0.0049
52 CAROTID ARTERY DISEASE 6 0.0047
53 HAEMORRHAGIC ANAEMIA 20 0.0045
54 NEPHROSCLEROSIS 5 0.0045
55 ESSENTIAL HYPERTENSION 8 0.0044
56 RHONCHI 6 0.0043
57 HYPORESPONSIVE TO STIMULI 5 0.0043
58 BLADDER DISORDER 41 0.0041
59 CAROTID ARTERY STENOSIS 14 0.0040
60 BLOOD PRESSURE DIASTOLIC DECREASED 29 0.0039
61 LEFT ATRIAL DILATATION 5 0.0039
62 BLOOD PRESSURE INADEQUATELY CONTROLLED 23 0.0038
63 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64 0.0038
64 URINE FLOW DECREASED 9 0.0038
65 DECREASED ACTIVITY 40 0.0037
66 NEOPLASM 42 0.0037
67 HYPOTENSION 717 0.0036
68 CORONARY ARTERIAL STENT INSERTION 18 0.0035
69 SPINAL OSTEOARTHRITIS 31 0.0035
70 BLOOD PRESSURE SYSTOLIC INCREASED 68 0.0035
71 SPONDYLOLISTHESIS 6 0.0035
72 END STAGE RENAL DISEASE 62 0.0034
73 FEAR OF DISEASE 6 0.0034
74 GUILLAIN-BARRE SYNDROME 16 0.0033
75 HAEMATOCRIT DECREASED 65 0.0033
76 CONSTIPATION 714 0.0033
77 JOINT DESTRUCTION 5 0.0032
78 INFREQUENT BOWEL MOVEMENTS 8 0.0032
79 TOXICITY TO VARIOUS AGENTS 536 0.0032
80 ANGINA PECTORIS 91 0.0032
81 ORTHOPNOEA 10 0.0031
82 RADICULOPATHY 8 0.0030
83 BREAST DISORDER 6 0.0029
84 DILATATION VENTRICULAR 6 0.0029
85 FALL 908 0.0027
86 AORTIC ARTERIOSCLEROSIS 7 0.0027
87 DYSPNOEA EXERTIONAL 102 0.0027
88 BRONCHIECTASIS 18 0.0027
89 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 11 0.0026
90 GLYCOSYLATED HAEMOGLOBIN INCREASED 66 0.0026
91 AORTIC STENOSIS 9 0.0026
92 NEPHROPATHY 24 0.0026
93 DYSLIPIDAEMIA 13 0.0026
94 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
95 SELF ESTEEM DECREASED 6 0.0025
96 POLYCYTHAEMIA 5 0.0024
97 PRODUCTIVE COUGH 115 0.0024
98 SUBILEUS 5 0.0024
99 BLOOD PRESSURE DIASTOLIC ABNORMAL 6 0.0024
100 HEPATOSPLENOMEGALY 6 0.0023
101 LOSS OF EMPLOYMENT 7 0.0023
102 JAW FRACTURE 5 0.0023
103 ISCHAEMIC CARDIOMYOPATHY 7 0.0023
104 LIMB MASS 5 0.0023
105 CHRONIC KIDNEY DISEASE 173 0.0023
106 ANGIONEUROTIC OEDEMA 6 0.0022
107 ARTERIOSCLEROSIS 21 0.0022
108 DIABETIC NEUROPATHY 11 0.0022
109 RENAL FAILURE CHRONIC 17 0.0022
110 HYPOTONIA 22 0.0022
111 REACTION TO EXCIPIENT 5 0.0022
112 ELECTROCARDIOGRAM ABNORMAL 17 0.0022
113 GAMMA-GLUTAMYLTRANSFERASE INCREASED 47 0.0021
114 HIGH DENSITY LIPOPROTEIN DECREASED 7 0.0021
115 RED BLOOD CELL COUNT DECREASED 59 0.0021
116 BILIARY COLIC 6 0.0021
117 URINE ODOUR ABNORMAL 12 0.0020
118 EOSINOPHIL COUNT INCREASED 17 0.0020
119 DEMENTIA 57 0.0020
120 BLOOD POTASSIUM DECREASED 61 0.0020
121 URINE ANALYSIS ABNORMAL 6 0.0020
122 AZOTAEMIA 8 0.0020
123 BLOOD PRESSURE FLUCTUATION 48 0.0020
124 METABOLIC ENCEPHALOPATHY 6 0.0020
125 CEREBROVASCULAR DISORDER 6 0.0020
126 CORONARY ARTERY STENOSIS 10 0.0020
127 PEMPHIGOID 15 0.0020
128 ECONOMIC PROBLEM 30 0.0020
129 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
130 RESPIRATORY RATE INCREASED 17 0.0019
131 BUNDLE BRANCH BLOCK LEFT 8 0.0019
132 HYPOVOLAEMIA 11 0.0019
133 LOWER RESPIRATORY TRACT INFECTION 85 0.0019
134 VENTRICULAR HYPOKINESIA 6 0.0019
135 UPPER RESPIRATORY TRACT INFECTION 86 0.0019
136 FREQUENT BOWEL MOVEMENTS 50 0.0018
137 LOSS OF CONTROL OF LEGS 7 0.0018
138 ANGINA UNSTABLE 12 0.0018
139 RENAL TUBULAR NECROSIS 18 0.0018
140 CLONUS 5 0.0018
141 RENAL FAILURE ACUTE 77 0.0018
142 THERAPEUTIC AGENT TOXICITY 6 0.0018
143 PROSTATOMEGALY 7 0.0018
144 MITRAL VALVE INCOMPETENCE 20 0.0018
145 WHEEZING 104 0.0018
146 BRONCHOPNEUMONIA 6 0.0018
147 CARDIAC VALVE DISEASE 10 0.0017
148 PSYCHOLOGICAL TRAUMA 15 0.0017
149 PERIORBITAL OEDEMA 9 0.0017
150 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
151 HYPERTONIC BLADDER 5 0.0017
152 LUMBAR SPINAL STENOSIS 5 0.0017
153 BLOOD CALCIUM INCREASED 15 0.0017
154 TROPONIN INCREASED 13 0.0017
155 HYPERKALAEMIA 59 0.0017
156 CORONARY ARTERY OCCLUSION 23 0.0017
157 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
158 ATYPICAL PNEUMONIA 5 0.0017
159 HYPERCAPNIA 5 0.0017
160 EXPIRED PRODUCT ADMINISTERED 55 0.0017
161 MONOCYTE COUNT INCREASED 6 0.0017
162 AORTIC VALVE INCOMPETENCE 7 0.0016
163 LUNG NEOPLASM 7 0.0016
164 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
165 TRICUSPID VALVE INCOMPETENCE 13 0.0016
166 GASTRIC ULCER HAEMORRHAGE 9 0.0016
167 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
168 NASAL CONGESTION 94 0.0016
169 LYMPHOEDEMA 11 0.0016
170 HYPERLIPIDAEMIA 19 0.0016
171 LARGE INTESTINE POLYP 11 0.0016
172 BREAST CANCER RECURRENT 5 0.0016
173 AUTOIMMUNE HEPATITIS 11 0.0016
174 MYOCARDITIS 18 0.0016
175 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 8 0.0016
176 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0015
177 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
178 HAEMORRHAGIC STROKE 12 0.0015
179 INJURY 107 0.0015
180 WALKING AID USER 10 0.0015
181 RENAL INJURY 45 0.0015
182 CHROMATURIA 34 0.0015
183 ATRIAL FLUTTER 12 0.0015
184 CARDIAC MURMUR 13 0.0015
185 LEUKOCYTOSIS 27 0.0015
186 ANGIOEDEMA 66 0.0015
187 CORONARY ARTERY DISEASE 45 0.0015
188 TOOTH DISORDER 33 0.0015
189 B-CELL LYMPHOMA 5 0.0015
190 CARDIAC FAILURE CONGESTIVE 118 0.0015
191 PARALYSIS 21 0.0015
192 SUDDEN CARDIAC DEATH 5 0.0015
193 RECTAL HAEMORRHAGE 63 0.0015
194 RHABDOMYOLYSIS 61 0.0015
195 LEFT VENTRICULAR FAILURE 5 0.0015
196 ATELECTASIS 14 0.0014
197 CONGESTIVE CARDIOMYOPATHY 6 0.0014
198 MULTIPLE INJURIES 9 0.0014
199 HEART RATE DECREASED 50 0.0014
200 LIP OEDEMA 6 0.0014
201 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
202 DEPRESSED MOOD 74 0.0014
203 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
204 CORONARY ARTERY BYPASS 8 0.0014
205 ACUTE MYOCARDIAL INFARCTION 41 0.0014
206 HAIR COLOUR CHANGES 17 0.0014
207 VARICOSE VEIN 7 0.0014
208 STOMACH DISCOMFORT 7 0.0014
209 CARDIOTOXICITY 12 0.0013
210 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
211 RETINOPATHY 5 0.0013
212 BREAST MASS 9 0.0013
213 HAIR DISORDER 11 0.0013
214 FACE INJURY 5 0.0013
215 RHINORRHOEA 85 0.0013
216 INTERNAL HAEMORRHAGE 15 0.0013
217 PARANASAL SINUS HYPERSECRETION 5 0.0013
218 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
219 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
220 INTERNATIONAL NORMALISED RATIO INCREASED 37 0.0013
221 STRESS FRACTURE 7 0.0013
222 COLITIS 49 0.0013
223 FEELING OF DESPAIR 6 0.0013
224 MUSCLE RUPTURE 5 0.0013
225 NASAL DRYNESS 8 0.0013
226 DRUG INTERACTION 202 0.0013
227 SPINAL COLUMN STENOSIS 6 0.0013
228 THERMAL BURN 9 0.0013
229 DIVERTICULUM 9 0.0013
230 PULSE ABSENT 6 0.0013
231 CATARACT 75 0.0013
232 FAECAL INCONTINENCE 6 0.0012
233 APHAGIA 6 0.0012
234 ROTATOR CUFF SYNDROME 16 0.0012
235 CARDIAC FLUTTER 8 0.0012
236 PAIN 758 0.0012
237 BLOOD POTASSIUM INCREASED 20 0.0012
238 VITAMIN D DEFICIENCY 12 0.0012
239 MYOCARDIAL ISCHAEMIA 14 0.0012
240 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
241 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
242 PRODUCT SUBSTITUTION ISSUE 69 0.0012
243 BLOOD PRESSURE INCREASED 183 0.0012
244 HAIR TEXTURE ABNORMAL 16 0.0012
245 JOINT RANGE OF MOTION DECREASED 16 0.0012
246 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
247 ASPARTATE AMINOTRANSFERASE INCREASED 63 0.0012
248 ACUTE KIDNEY INJURY 181 0.0012
249 SINUS HEADACHE 7 0.0012
250 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
251 CARDIAC FAILURE CHRONIC 5 0.0012
252 GASTROINTESTINAL HAEMORRHAGE 98 0.0012
253 PROTHROMBIN TIME PROLONGED 7 0.0012
254 VENTRICULAR EXTRASYSTOLES 12 0.0012
255 SWOLLEN TONGUE 36 0.0012
256 LOCAL SWELLING 20 0.0011
257 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 55 0.0011
258 RENAL FAILURE 152 0.0011
259 GRIP STRENGTH DECREASED 10 0.0011
260 RENAL CYST 9 0.0011
261 LUNG INFILTRATION 10 0.0011
262 NO ADVERSE EVENT 205 0.0011
263 PHARYNGITIS 14 0.0011
264 EYE HAEMORRHAGE 15 0.0011
265 BLOOD GLUCOSE INCREASED 211 0.0011
266 SENSORY LOSS 9 0.0011
267 BLOOD SODIUM DECREASED 21 0.0011
268 CHEST DISCOMFORT 114 0.0011
269 SINUS CONGESTION 15 0.0011
270 HEART RATE IRREGULAR 25 0.0011
271 BLOOD GLUCOSE DECREASED 53 0.0011
272 INFLUENZA 123 0.0011
273 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
274 ARRHYTHMIA 52 0.0011
275 MAJOR DEPRESSION 8 0.0011
276 METABOLIC ACIDOSIS 35 0.0011
277 EJECTION FRACTION DECREASED 17 0.0011
278 SEROTONIN SYNDROME 21 0.0011
279 EAR DISORDER 5 0.0011
280 INJECTION SITE NODULE 12 0.0011
281 MOVEMENT DISORDER 35 0.0011
282 SYNCOPE 109 0.0011
283 PROSTATIC SPECIFIC ANTIGEN INCREASED 15 0.0011
284 CHOKING SENSATION 6 0.0011
285 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
286 SYNOVIAL CYST 5 0.0011
287 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
288 HEART RATE ABNORMAL 6 0.0011
289 PULMONARY MASS 16 0.0011
290 FLUSHING 109 0.0011
291 GOUT 19 0.0011
292 CHOLECYSTITIS ACUTE 6 0.0011
293 CARDIOMEGALY 13 0.0011
294 BLOOD COUNT ABNORMAL 16 0.0011
295 TENDON RUPTURE 13 0.0011
296 VITAMIN D DECREASED 9 0.0011
297 AORTIC ANEURYSM 8 0.0011
298 VISUAL DISTURBANCE 6 0.0010
299 LIPASE INCREASED 8 0.0010
300 HYPOVOLAEMIC SHOCK 5 0.0010
301 GASTROOESOPHAGEAL REFLUX DISEASE 84 0.0010
302 PHARMACEUTICAL PRODUCT COMPLAINT 27 0.0010
303 ATRIAL FIBRILLATION 101 0.0010
304 ATRIOVENTRICULAR BLOCK 8 0.0010
305 RASH VESICULAR 5 0.0010
306 CONCUSSION 8 0.0010
307 COLITIS ULCERATIVE 46 0.0010
308 CHEST PAIN 190 0.0010
309 ECCHYMOSIS 7 0.0010
310 COELIAC DISEASE 10 0.0010
311 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 53 0.0010
312 BLOOD UREA INCREASED 17 0.0010
313 JOINT EFFUSION 7 0.0010
314 CARDIOMYOPATHY 15 0.0010
315 HEPARIN-INDUCED THROMBOCYTOPENIA 5 0.0010
316 BREATH SOUNDS ABNORMAL 5 0.0010
317 HAIR GROWTH ABNORMAL 7 0.0010
318 BLOOD IRON DECREASED 12 0.0010
319 TYPE 2 DIABETES MELLITUS 34 0.0010
320 ANOREXIA 13 0.0010
321 EXTRAPYRAMIDAL DISORDER 25 0.0010
322 CARDIAC PACEMAKER INSERTION 6 0.0010
323 SCIATICA 16 0.0010
324 EXTRASYSTOLES 7 0.0010
325 HAEMOGLOBIN DECREASED 102 0.0010
326 STENT PLACEMENT 8 0.0010
327 EMPHYSEMA 10 0.0010
328 EXOSTOSIS 9 0.0010
329 ASTHMA 111 0.0010
330 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
331 DIVERTICULITIS 27 0.0010
332 INCREASED UPPER AIRWAY SECRETION 5 0.0010
333 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
334 INJECTION SITE EXTRAVASATION 12 0.0010
335 PERIPHERAL VASCULAR DISORDER 5 0.0010
336 VENTRICULAR TACHYCARDIA 16 0.0010
337 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
338 HEPATIC STEATOSIS 18 0.0010
339 FAILURE TO THRIVE 5 0.0010
340 BRADYCARDIA 51 0.0010
341 PRE-EXISTING CONDITION IMPROVED 6 0.0010
342 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
343 DRUG TOXICITY 13 0.0010
344 HAEMODIALYSIS 8 0.0010
345 RENAL IMPAIRMENT 80 0.0010
346 OEDEMA PERIPHERAL 116 0.0010
347 TRANSIENT ISCHAEMIC ATTACK 32 0.0009
348 NYSTAGMUS 5 0.0009
349 BODY HEIGHT DECREASED 10 0.0009
350 FOOD POISONING 5 0.0009
351 PROCTALGIA 6 0.0009
352 CARPAL TUNNEL SYNDROME 13 0.0009
353 LACTIC ACIDOSIS 30 0.0009
354 MUSCLE STRAIN 8 0.0009
355 DYSURIA 34 0.0009
356 HAEMORRHOIDS 18 0.0009
357 BLOOD GLUCOSE ABNORMAL 17 0.0009
358 OSTEOARTHRITIS 39 0.0009
359 URINE OUTPUT DECREASED 8 0.0009
360 WEIGHT DECREASED 255 0.0009
361 GROIN PAIN 8 0.0009
362 PHARYNGEAL OEDEMA 14 0.0009
363 HAEMATURIA 31 0.0009
364 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
365 DYSPNOEA 508 0.0009
366 BLOOD URINE PRESENT 17 0.0009
367 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
368 SKIN ULCER 23 0.0009
369 SKIN TOXICITY 5 0.0009
370 OSTEOPOROSIS 36 0.0009
371 HYPONATRAEMIA 49 0.0009
372 SHOCK 20 0.0009
373 INCREASED TENDENCY TO BRUISE 8 0.0009
374 EXERCISE TOLERANCE DECREASED 5 0.0009
375 MENTAL STATUS CHANGES 24 0.0009
376 PETECHIAE 9 0.0009
377 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
378 COUGH 239 0.0009
379 INCONTINENCE 9 0.0009
380 HAND FRACTURE 6 0.0008
381 SPUTUM DISCOLOURED 8 0.0008
382 COAGULOPATHY 14 0.0008
383 LUNG INFECTION 13 0.0008
384 OXYGEN SATURATION DECREASED 47 0.0008
385 DISORIENTATION 33 0.0008
386 GANGRENE 5 0.0008
387 HEPATITIS B 5 0.0008
388 DRUG ABUSE 69 0.0008
389 HYPERCHOLESTEROLAEMIA 8 0.0008
390 SKIN LACERATION 9 0.0008
391 FEELING COLD 23 0.0008
392 HAEMOPTYSIS 23 0.0008
393 OESOPHAGITIS 9 0.0008
394 MUSCULOSKELETAL PAIN 43 0.0008
395 DENTAL CARIES 9 0.0008
396 MENISCUS INJURY 5 0.0008
397 BRONCHITIS 60 0.0008
398 OLIGURIA 5 0.0008
399 MALNUTRITION 9 0.0008
400 NEPHROPATHY TOXIC 9 0.0008
401 PURPURA 7 0.0008
402 TOOTH ABSCESS 8 0.0008
403 HYPOGLYCAEMIA 38 0.0008
404 FEAR 21 0.0008
405 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
406 DELIRIUM 27 0.0008
407 LIMB DISCOMFORT 24 0.0008
408 HYPERTENSION 164 0.0008
409 INCOHERENT 5 0.0008
410 MELAENA 17 0.0008
411 HIATUS HERNIA 10 0.0008
412 PELVIC FRACTURE 6 0.0008
413 NASOPHARYNGITIS 142 0.0008
414 CARDIOGENIC SHOCK 11 0.0008
415 MUSCULAR WEAKNESS 87 0.0008
416 POLYP 5 0.0008
417 ABNORMAL DREAMS 21 0.0008
418 ATAXIA 9 0.0008
419 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
420 SOPOR 10 0.0008
421 OBESITY 12 0.0008
422 ASTHENIA 283 0.0008
423 HIP FRACTURE 24 0.0007
424 LACERATION 7 0.0007
425 NOCTURIA 9 0.0007
426 HYPERGLYCAEMIA 27 0.0007
427 FLATULENCE 42 0.0007
428 COLON CANCER 11 0.0007
429 BACK DISORDER 12 0.0007
430 SHOCK HAEMORRHAGIC 6 0.0007
431 PROTEINURIA 14 0.0007
432 HAEMORRHAGE INTRACRANIAL 11 0.0007
433 SLEEP APNOEA SYNDROME 14 0.0007
434 PAIN IN EXTREMITY 216 0.0007
435 BLOOD GLUCOSE FLUCTUATION 8 0.0007
436 PHOTOSENSITIVITY REACTION 12 0.0007
437 OSTEOPENIA 11 0.0007
438 ACUTE CORONARY SYNDROME 6 0.0007
439 SINUS BRADYCARDIA 7 0.0007
440 PLATELET COUNT DECREASED 77 0.0007
441 DIZZINESS POSTURAL 7 0.0007
442 DYSPEPSIA 71 0.0007
443 AGEUSIA 18 0.0007
444 POLLAKIURIA 30 0.0007
445 PARKINSONISM 7 0.0007
446 HUNGER 10 0.0007
447 RESTLESS LEGS SYNDROME 13 0.0007
448 KNEE ARTHROPLASTY 15 0.0007
449 DEHYDRATION 95 0.0007
450 FACE OEDEMA 12 0.0007
451 BODY TEMPERATURE DECREASED 7 0.0007
452 HALLUCINATION, VISUAL 15 0.0007
453 CARDIAC FAILURE 57 0.0007
454 INSOMNIA 189 0.0007
455 SEASONAL ALLERGY 10 0.0007
456 SINUS TACHYCARDIA 10 0.0007
457 RETCHING 15 0.0007
458 LOCALISED INFECTION 17 0.0007
459 PANCREATITIS 37 0.0007
460 MYOCARDIAL INFARCTION 122 0.0007
461 SPINAL FRACTURE 14 0.0007
462 UNRESPONSIVE TO STIMULI 18 0.0007
463 BLOOD MAGNESIUM DECREASED 6 0.0007
464 VISUAL ACUITY REDUCED 23 0.0007
465 PERICARDIAL EFFUSION 16 0.0007
466 FAECES DISCOLOURED 15 0.0007
467 SKIN SWELLING 6 0.0007
468 DERMATITIS BULLOUS 5 0.0007
469 MADAROSIS 8 0.0007
470 RESPIRATORY DISTRESS 19 0.0007
471 FEELING HOT 42 0.0007
472 DYSSTASIA 20 0.0007
473 ORAL CANDIDIASIS 9 0.0007
474 METASTASES TO LIVER 12 0.0007
475 DIABETES MELLITUS 52 0.0007
476 ORAL DISORDER 5 0.0007
477 EPISTAXIS 51 0.0007
478 HELICOBACTER INFECTION 7 0.0007
479 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
480 ARTHRITIS 53 0.0007
481 ABDOMINAL DISCOMFORT 113 0.0007
482 ISCHAEMIC STROKE 12 0.0007
483 RESPIRATORY FAILURE 49 0.0007
484 SUNBURN 5 0.0007
485 GLOSSODYNIA 15 0.0007
486 ORAL PAIN 15 0.0007
487 WRIST FRACTURE 8 0.0007
488 HEART RATE INCREASED 66 0.0007
489 DIABETIC KETOACIDOSIS 16 0.0007
490 DRY MOUTH 54 0.0007
491 HYPOAESTHESIA 99 0.0007
492 LIP SWELLING 22 0.0007
493 BLOOD CREATININE INCREASED 43 0.0007
494 BONE DISORDER 12 0.0007
495 PRESYNCOPE 16 0.0007
496 NEURALGIA 16 0.0007
497 PANCREATIC CARCINOMA 19 0.0007
498 PERIPHERAL COLDNESS 9 0.0007
499 JOINT SWELLING 79 0.0007
500 ACIDOSIS 5 0.0007
501 BLOOD PRESSURE ABNORMAL 13 0.0007
502 BOWEL MOVEMENT IRREGULARITY 5 0.0007
503 POOR QUALITY SLEEP 14 0.0006
504 SMALL INTESTINAL OBSTRUCTION 8 0.0006
505 HEMIPARESIS 11 0.0006
506 PRURITUS GENERALISED 14 0.0006
507 DYSGEUSIA 48 0.0006
508 CIRCULATORY COLLAPSE 11 0.0006
509 TENDONITIS 10 0.0006
510 NECK PAIN 36 0.0006
511 DEFORMITY 6 0.0006
512 MUSCULOSKELETAL DISCOMFORT 11 0.0006
513 HEPATIC CIRRHOSIS 12 0.0006
514 GASTROINTESTINAL INFLAMMATION 5 0.0006
515 MULTIPLE ALLERGIES 5 0.0006
516 CEREBROVASCULAR ACCIDENT 108 0.0006
517 TOOTH FRACTURE 7 0.0006
518 RIB FRACTURE 13 0.0006
519 GINGIVAL PAIN 5 0.0006
520 SEPSIS 70 0.0006
521 URTICARIA 105 0.0006
522 RASH PAPULAR 14 0.0006
523 ACUTE RESPIRATORY FAILURE 12 0.0006
524 CONTUSION 60 0.0006
525 ERECTILE DYSFUNCTION 16 0.0006
526 INTENTIONAL DRUG MISUSE 13 0.0006
527 RHINITIS 5 0.0006
528 BACK PAIN 144 0.0006
529 FRUSTRATION TOLERANCE DECREASED 5 0.0006
530 FLUID OVERLOAD 9 0.0006
531 HAEMATOMA 16 0.0006
532 MALAISE 270 0.0006
533 FEMUR FRACTURE 19 0.0006
534 MICTURITION URGENCY 7 0.0006
535 DYSARTHRIA 23 0.0006
536 VITREOUS FLOATERS 6 0.0006
537 HICCUPS 5 0.0006
538 CONFUSIONAL STATE 98 0.0006
539 MUSCLE SPASMS 111 0.0006
540 SPINAL COMPRESSION FRACTURE 5 0.0006
541 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 43 0.0006
542 PERIPHERAL SWELLING 93 0.0006
543 PULMONARY OEDEMA 27 0.0006
544 POST PROCEDURAL HAEMORRHAGE 7 0.0006
545 GAIT DISTURBANCE 115 0.0006
546 HEAD INJURY 19 0.0006
547 HYPOXIA 21 0.0006
548 APHASIA 18 0.0006
549 FULL BLOOD COUNT DECREASED 12 0.0006
550 MYALGIA 101 0.0006
551 ABDOMINAL DISTENSION 62 0.0006
552 MUSCULOSKELETAL STIFFNESS 52 0.0006
553 SENSATION OF FOREIGN BODY 5 0.0006
554 HAEMATEMESIS 15 0.0006
555 FLUID RETENTION 30 0.0006
556 PALLOR 16 0.0006
557 BLOOD PRESSURE DECREASED 39 0.0006
558 MUSCLE RIGIDITY 7 0.0006
559 INITIAL INSOMNIA 6 0.0006
560 LIVER FUNCTION TEST ABNORMAL 17 0.0006
561 THYROID DISORDER 9 0.0006
562 EMOTIONAL DISORDER 18 0.0006
563 GASTRIC DISORDER 20 0.0006
564 DIARRHOEA 376 0.0006
565 LYMPHOMA 9 0.0006
566 CARDIAC OPERATION 5 0.0006
567 ANKLE FRACTURE 9 0.0006
568 DELUSION 9 0.0006
569 HYPERBILIRUBINAEMIA 6 0.0006
570 GASTRIC ULCER 11 0.0006
571 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
572 DIZZINESS 288 0.0006
573 CELLULITIS 29 0.0006
574 PLEURAL EFFUSION 35 0.0006
575 URINARY INCONTINENCE 17 0.0006
576 COORDINATION ABNORMAL 8 0.0006
577 TRANSFUSION 6 0.0006
578 SPEECH DISORDER 30 0.0006
579 RHEUMATOID ARTHRITIS 65 0.0006
580 OEDEMA 31 0.0006
581 ANHEDONIA 15 0.0006
582 CARDIAC ARREST 47 0.0006
583 INCORRECT DRUG ADMINISTRATION DURATION 16 0.0006
584 SWELLING FACE 37 0.0006
585 PNEUMOTHORAX 9 0.0006
586 BLINDNESS UNILATERAL 8 0.0006
587 SINUSITIS 58 0.0006
588 SKIN DISCOLOURATION 26 0.0006
589 NAUSEA 446 0.0006
590 ILEUS 7 0.0006
591 TOOTH EXTRACTION 7 0.0006
592 FACIAL PAIN 5 0.0006
593 JAUNDICE 15 0.0006
594 DRUG EFFECT DECREASED 30 0.0006
595 SINUS DISORDER 11 0.0006
596 PRODUCT QUALITY ISSUE 75 0.0006
597 FEELING ABNORMAL 132 0.0006
598 PULMONARY THROMBOSIS 6 0.0005
599 CARDIO-RESPIRATORY ARREST 23 0.0005
600 PYREXIA 190 0.0005
601 CHOLELITHIASIS 18 0.0005
602 DRUG INTOLERANCE 53 0.0005
603 WOUND INFECTION 6 0.0005
604 DYSPHONIA 32 0.0005
605 RESPIRATORY ARREST 15 0.0005
606 UNEVALUABLE EVENT 41 0.0005
607 BURNING SENSATION 38 0.0005
608 IRON DEFICIENCY ANAEMIA 5 0.0005
609 FOOT DEFORMITY 6 0.0005
610 VENTRICULAR FIBRILLATION 6 0.0005
611 SKIN HAEMORRHAGE 8 0.0005
612 DEEP VEIN THROMBOSIS 35 0.0005
613 NERVOUSNESS 28 0.0005
614 HYPERHIDROSIS 69 0.0005
615 RASH PRURITIC 29 0.0005
616 PNEUMONIA 173 0.0005
617 CANDIDA INFECTION 9 0.0005
618 TOOTH INFECTION 7 0.0005
619 SARS-COV-2 TEST POSITIVE 7 0.0005
620 FOOT FRACTURE 10 0.0005
621 ABASIA 13 0.0005
622 SCAB 6 0.0005
623 FEELING JITTERY 10 0.0005
624 ANAEMIA 100 0.0005
625 CRYING 19 0.0005
626 MULTI-ORGAN FAILURE 9 0.0005
627 HYPOKALAEMIA 24 0.0005
628 GLAUCOMA 10 0.0005
629 OROPHARYNGEAL PAIN 48 0.0005
630 MUSCULOSKELETAL CHEST PAIN 8 0.0005
631 RENAL DISORDER 24 0.0005
632 TACHYPNOEA 7 0.0005
633 IMPAIRED WORK ABILITY 11 0.0005
634 EAR PAIN 10 0.0005
635 INFUSION RELATED REACTION 34 0.0005
636 SWELLING 48 0.0005
637 HYPOACUSIS 22 0.0005
638 SKIN CANCER 11 0.0005
639 DEPRESSION 116 0.0005
640 URINARY RETENTION 17 0.0005
641 SOMNOLENCE 102 0.0005
642 HOSPICE CARE 5 0.0005
643 VOMITING 238 0.0005
644 BACTERAEMIA 6 0.0005
645 PALPITATIONS 59 0.0005
646 THIRST 9 0.0005
647 RESPIRATORY TRACT CONGESTION 8 0.0005
648 MACULAR DEGENERATION 6 0.0005
649 RASH GENERALISED 13 0.0005
650 PRESCRIBED UNDERDOSE 10 0.0005
651 PRURITUS 192 0.0005
652 NIGHT SWEATS 16 0.0005
653 PRODUCT PHYSICAL ISSUE 10 0.0005
654 DRUG EFFECT INCOMPLETE 18 0.0005
655 BURSITIS 6 0.0005
656 FIBROMYALGIA 12 0.0005
657 TREATMENT NONCOMPLIANCE 27 0.0005
658 ARTHRALGIA 205 0.0005
659 DYSKINESIA 20 0.0005
660 NO THERAPEUTIC RESPONSE 6 0.0005
661 DRUG LEVEL DECREASED 5 0.0005
662 SNEEZING 11 0.0005
663 PANCREATITIS ACUTE 11 0.0005
664 SUBDURAL HAEMATOMA 7 0.0005
665 NEUTROPHIL COUNT INCREASED 5 0.0005
666 PRODUCT USE IN UNAPPROVED INDICATION 121 0.0005
667 VISION BLURRED 67 0.0005
668 THERAPY CESSATION 25 0.0005
669 INJECTION SITE MASS 18 0.0005
670 HYPERCALCAEMIA 6 0.0005
671 APPLICATION SITE PRURITUS 11 0.0005
672 CYST 6 0.0005
673 TOOTH LOSS 10 0.0005
674 HYPOKINESIA 7 0.0005
675 RASH ERYTHEMATOUS 23 0.0005
676 PULMONARY HYPERTENSION 10 0.0005
677 FATIGUE 372 0.0005
678 DRUG ADMINISTERED AT INAPPROPRIATE SITE 5 0.0005
679 BLOOD CHOLESTEROL INCREASED 22 0.0005
680 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
681 CYSTITIS 15 0.0005
682 INCREASED APPETITE 9 0.0005
683 CARDIAC DISORDER 44 0.0005
684 HYPOTHYROIDISM 15 0.0005
685 HEPATIC ENZYME INCREASED 32 0.0005
686 PULMONARY FIBROSIS 9 0.0005
687 EYE IRRITATION 27 0.0005
688 INTENTIONAL PRODUCT MISUSE 41 0.0005
689 LOSS OF CONSCIOUSNESS 60 0.0005
690 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
691 BLINDNESS 19 0.0005
692 HEREDITARY ANGIOEDEMA 5 0.0005
693 LIVER FUNCTION TEST INCREASED 10 0.0005
694 PRESCRIBED OVERDOSE 9 0.0005
695 DECREASED APPETITE 108 0.0005
696 HYPOAESTHESIA ORAL 7 0.0005
697 LACRIMATION INCREASED 14 0.0005
698 ABDOMINAL PAIN UPPER 95 0.0005
699 SKIN FISSURES 9 0.0005
700 ANXIETY 131 0.0005
701 BACK INJURY 5 0.0005
702 DRUG DOSE OMISSION 76 0.0005
703 DRUG DISPENSING ERROR 7 0.0005
704 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
705 HIP ARTHROPLASTY 7 0.0005
706 IMPAIRED HEALING 15 0.0005
707 GASTRITIS 12 0.0005
708 DISABILITY 9 0.0005
709 CONVULSION 26 0.0005
710 HAEMATOCHEZIA 25 0.0005
711 INTESTINAL OBSTRUCTION 17 0.0005
712 NERVE INJURY 5 0.0004
713 BASAL CELL CARCINOMA 7 0.0004
714 ALOPECIA 88 0.0004
715 QUALITY OF LIFE DECREASED 6 0.0004
716 WEIGHT INCREASED 100 0.0004
717 TREMOR 74 0.0004
718 AMNESIA 29 0.0004
719 INTENTIONAL PRODUCT USE ISSUE 39 0.0004
720 BLOOD BILIRUBIN INCREASED 12 0.0004
721 CHILLS 52 0.0004
722 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
723 EYE INFECTION 5 0.0004
724 LABORATORY TEST ABNORMAL 13 0.0004
725 OVERDOSE 95 0.0004
726 PNEUMONIA ASPIRATION 11 0.0004
727 IMPAIRED GASTRIC EMPTYING 6 0.0004
728 IMPAIRED DRIVING ABILITY 5 0.0004
729 GINGIVAL BLEEDING 6 0.0004
730 SLEEP DISORDER 31 0.0004
731 INJECTION SITE HAEMORRHAGE 35 0.0004
732 HOT FLUSH 33 0.0004
733 CHOLECYSTECTOMY 5 0.0004
734 PLASMA CELL MYELOMA 17 0.0004
735 ABDOMINAL PAIN LOWER 11 0.0004
736 LETHARGY 25 0.0004
737 NEUROPATHY PERIPHERAL 41 0.0004
738 HYPOPHAGIA 11 0.0004
739 LUNG DISORDER 21 0.0004
740 MIDDLE INSOMNIA 8 0.0004
741 BLOOD TEST ABNORMAL 6 0.0004
742 SPLENOMEGALY 5 0.0004
743 DISCOMFORT 26 0.0004
744 LYMPHADENOPATHY 15 0.0004
745 DIALYSIS 6 0.0004
746 MUSCULOSKELETAL DISORDER 8 0.0004
747 ERYTHEMA 86 0.0004
748 IMPAIRED QUALITY OF LIFE 6 0.0004
749 CHOLESTASIS 8 0.0004
750 LOWER LIMB FRACTURE 8 0.0004
751 URINARY TRACT INFECTION 71 0.0004
752 ANOSMIA 6 0.0004
753 HYPERTHYROIDISM 6 0.0004
754 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
755 INJECTION SITE HAEMATOMA 6 0.0004
756 ILL-DEFINED DISORDER 25 0.0004
757 ORAL HERPES 8 0.0004
758 ROAD TRAFFIC ACCIDENT 17 0.0004
759 PARANOIA 7 0.0004
760 PSORIASIS 53 0.0004
761 IMMUNODEFICIENCY 6 0.0004
762 RESPIRATORY DISORDER 12 0.0004
763 PARAESTHESIA 63 0.0004
764 DYSPHAGIA 38 0.0004
765 HALLUCINATION 30 0.0004
766 DERMATITIS ALLERGIC 5 0.0004
767 COLD SWEAT 7 0.0004
768 AGITATION 29 0.0004
769 CONDITION AGGRAVATED 120 0.0004
770 DEVICE FAILURE 6 0.0004
771 TACHYCARDIA 35 0.0004
772 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
773 NEPHROLITHIASIS 18 0.0004
774 ABDOMINAL PAIN 91 0.0004
775 SEPTIC SHOCK 17 0.0004
776 MYDRIASIS 5 0.0004
777 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
778 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
779 SYNOVITIS 7 0.0004
780 DRUG INEFFECTIVE 510 0.0004
781 TOOTHACHE 7 0.0004
782 THROMBOSIS 31 0.0004
783 ANGER 13 0.0004
784 UNDERDOSE 28 0.0004
785 NODULE 5 0.0004
786 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
787 APPLICATION SITE ERYTHEMA 10 0.0004
788 HEADACHE 239 0.0004
789 INCORRECT PRODUCT STORAGE 5 0.0004
790 PULMONARY CONGESTION 5 0.0004
791 THROAT IRRITATION 17 0.0004
792 HALLUCINATION, AUDITORY 6 0.0004
793 ADVERSE REACTION 5 0.0004
794 BACTERIAL INFECTION 7 0.0004
795 JOINT INJURY 8 0.0004
796 BLISTER 21 0.0004
797 IRRITABLE BOWEL SYNDROME 8 0.0004
798 MEMORY IMPAIRMENT 51 0.0004
799 DISTURBANCE IN ATTENTION 20 0.0004
800 FRACTURE 7 0.0004
801 THROAT TIGHTNESS 10 0.0004
802 PSORIATIC ARTHROPATHY 15 0.0004
803 PRODUCT TASTE ABNORMAL 5 0.0004
804 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
805 ENCEPHALOPATHY 9 0.0004
806 EYE DISORDER 12 0.0004
807 POST PROCEDURAL COMPLICATION 7 0.0004
808 HAEMORRHAGE 38 0.0004
809 ERUCTATION 7 0.0004
810 DRY EYE 18 0.0004
811 SKIN DISORDER 12 0.0004
812 RASH 156 0.0004
813 PAIN IN JAW 10 0.0004
814 PRODUCT DOSE OMISSION 23 0.0004
815 UPPER LIMB FRACTURE 7 0.0004
816 SCAR 6 0.0004
817 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 63 0.0003
818 EYE SWELLING 13 0.0003
819 HYPERSOMNIA 10 0.0003
820 INFLAMMATION 18 0.0003
821 PULMONARY EMBOLISM 33 0.0003
822 MUSCLE TWITCHING 8 0.0003
823 NIGHTMARE 12 0.0003
824 PARAESTHESIA ORAL 5 0.0003
825 DIPLOPIA 9 0.0003
826 DISEASE PROGRESSION 41 0.0003
827 STOMATITIS 21 0.0003
828 NEOPLASM PROGRESSION 12 0.0003
829 DEVICE DISLOCATION 15 0.0003
830 NEEDLE ISSUE 10 0.0003
831 BODY TEMPERATURE INCREASED 7 0.0003
832 JOINT STIFFNESS 9 0.0003
833 APATHY 5 0.0003
834 ASCITES 10 0.0003
835 LYMPHOCYTE COUNT DECREASED 6 0.0003
836 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
837 EAR INFECTION 9 0.0003
838 GALLBLADDER DISORDER 6 0.0003
839 CEREBRAL HAEMORRHAGE 12 0.0003
840 GASTROENTERITIS VIRAL 6 0.0003
841 WHITE BLOOD CELL COUNT DECREASED 36 0.0003
842 OSTEOMYELITIS 6 0.0003
843 HERPES ZOSTER 19 0.0003
844 VIRAL INFECTION 11 0.0003
845 GAIT INABILITY 11 0.0003
846 HYPERSENSITIVITY 61 0.0003
847 SKIN LESION 9 0.0003
848 RESTLESSNESS 12 0.0003
849 CEREBRAL INFARCTION 8 0.0003
850 TINNITUS 15 0.0003
851 OSTEONECROSIS OF JAW 8 0.0003
852 AGRANULOCYTOSIS 6 0.0003
853 VISUAL IMPAIRMENT 40 0.0003
854 MENTAL DISORDER 14 0.0003
855 SKIN EXFOLIATION 27 0.0003
856 RASH MACULO-PAPULAR 7 0.0003
857 ABSCESS 5 0.0003
858 DEVICE MALFUNCTION 22 0.0003
859 DRUG PRESCRIBING ERROR 6 0.0003
860 VERTIGO 19 0.0003
861 HERNIA 6 0.0003
862 INTERSTITIAL LUNG DISEASE 15 0.0003
863 PRODUCT ADHESION ISSUE 11 0.0003
864 CHOKING 6 0.0003
865 INCORRECT DOSE ADMINISTERED 70 0.0003
866 ARTHROPATHY 17 0.0003
867 MEDICATION ERROR 17 0.0003
868 MULTIPLE FRACTURES 5 0.0003
869 INFLUENZA LIKE ILLNESS 25 0.0003
870 ABNORMAL BEHAVIOUR 12 0.0003
871 GASTROINTESTINAL DISORDER 27 0.0003
872 DRY SKIN 40 0.0003
873 OCULAR HYPERAEMIA 14 0.0003
874 OFF LABEL USE 258 0.0003
875 PNEUMONITIS 8 0.0003
876 DRUG ADMINISTRATION ERROR 9 0.0003
877 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
878 LUNG NEOPLASM MALIGNANT 12 0.0003
879 INJECTION SITE WARMTH 6 0.0003
880 ANAPHYLACTIC REACTION 16 0.0003
881 EOSINOPHILIA 5 0.0003
882 MOUTH ULCERATION 6 0.0003
883 SUICIDAL IDEATION 26 0.0003
884 HEAD DISCOMFORT 5 0.0003
885 ADVERSE EVENT 26 0.0003
886 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
887 EATING DISORDER 6 0.0003
888 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
889 SKIN BURNING SENSATION 20 0.0003
890 INJECTION SITE PAIN 85 0.0003
891 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
892 PELVIC PAIN 5 0.0003
893 DRUG RESISTANCE 7 0.0003
894 APPLICATION SITE PAIN 6 0.0003
895 PRODUCT USE ISSUE 51 0.0003
896 PSYCHOTIC DISORDER 8 0.0003
897 FUNGAL INFECTION 9 0.0003
898 STEVENS-JOHNSON SYNDROME 6 0.0003
899 CONJUNCTIVITIS 5 0.0003
900 HEPATOTOXICITY 6 0.0003
901 EYE PRURITUS 9 0.0003
902 PHOTOPHOBIA 5 0.0003
903 HYPOCALCAEMIA 5 0.0003
904 INFECTION 38 0.0003
905 MIGRAINE 25 0.0003
906 INJECTION SITE RASH 8 0.0003
907 PAIN OF SKIN 7 0.0003
908 LIMB INJURY 7 0.0003
909 MOOD ALTERED 7 0.0003
910 ADVERSE DRUG REACTION 23 0.0003
911 EMOTIONAL DISTRESS 31 0.0003
912 KIDNEY INFECTION 5 0.0003
913 DISEASE RECURRENCE 12 0.0003
914 PRODUCT PRESCRIBING ERROR 6 0.0003
915 PANCYTOPENIA 14 0.0003
916 WOUND 7 0.0003
917 IRRITABILITY 15 0.0002
918 EYE PAIN 14 0.0002
919 MENTAL IMPAIRMENT 6 0.0002
920 FEEDING DISORDER 5 0.0002
921 DEATH 208 0.0002
922 BONE PAIN 14 0.0002
923 INJECTION SITE BRUISING 19 0.0002
924 GASTRIC CANCER 6 0.0002
925 THROMBOCYTOPENIA 26 0.0002
926 COMA 11 0.0002
927 THERAPEUTIC RESPONSE DECREASED 14 0.0002
928 DEAFNESS 6 0.0002
929 NEOPLASM MALIGNANT 15 0.0002
930 BONE DENSITY DECREASED 7 0.0002
931 ILLNESS 23 0.0002
932 DRUG-INDUCED LIVER INJURY 7 0.0002
933 DEVICE ISSUE 20 0.0002
934 COVID-19 39 0.0002
935 SURGERY 13 0.0002
936 NEUTROPHIL COUNT DECREASED 9 0.0002
937 AGGRESSION 11 0.0002
938 PRODUCT AVAILABILITY ISSUE 5 0.0002
939 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
940 COMPLETED SUICIDE 18 0.0002
941 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
942 HEPATIC FUNCTION ABNORMAL 8 0.0002
943 TARDIVE DYSKINESIA 6 0.0002
944 STAPHYLOCOCCAL INFECTION 7 0.0002
945 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
946 INJECTION SITE ERYTHEMA 26 0.0002
947 INJECTION SITE URTICARIA 5 0.0002
948 LIVER INJURY 5 0.0002
949 INTENTIONAL OVERDOSE 13 0.0002
950 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
951 HEPATITIS 5 0.0002
952 INJECTION SITE PRURITUS 13 0.0002
953 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
954 VAGINAL HAEMORRHAGE 8 0.0002
955 INJECTION SITE SWELLING 14 0.0002
956 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
957 SUICIDE ATTEMPT 11 0.0002
958 ECZEMA 9 0.0002
959 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
960 MULTIPLE SCLEROSIS 8 0.0002
961 FEBRILE NEUTROPENIA 11 0.0002
962 C-REACTIVE PROTEIN INCREASED 6 0.0002
963 SEIZURE 19 0.0002
964 HOSPITALISATION 25 0.0002
965 BREAST CANCER 15 0.0002
966 NERVOUS SYSTEM DISORDER 5 0.0002
967 LIVER DISORDER 7 0.0002
968 MOOD SWINGS 5 0.0002
969 EXTRA DOSE ADMINISTERED 6 0.0001
970 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
971 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
972 LEUKOPENIA 7 0.0001
973 PANIC ATTACK 5 0.0001
974 ACCIDENTAL OVERDOSE 5 0.0001
975 THERAPY NON-RESPONDER 6 0.0001
976 PRODUCT DOSE OMISSION ISSUE 38 0.0001
977 DRUG WITHDRAWAL SYNDROME 11 0.0001
978 DEVICE LEAKAGE 5 0.0001
979 DERMATITIS ATOPIC 6 0.0001
980 SKIN IRRITATION 5 0.0001
981 RENAL CANCER 5 0.0001
982 BLADDER CANCER 6 0.0001
983 PROSTATE CANCER 8 0.0001
984 THERAPY INTERRUPTED 7 0.0001
985 NEUTROPENIA 12 0.0001
986 INJECTION SITE REACTION 5 0.0001
987 TREATMENT FAILURE 6 0.0001
988 PRODUCT STORAGE ERROR 6 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
990 ACNE 5 0.0001
991 DRUG DEPENDENCE 8 0.0000